Reprogramming of differentiated somatic cells into a pluripotent state (induced pluripotent stem cells, or iPSCs) has opened a veritable treasure trove of opportunities for regenerative medicine and basic research on human diseases. It is now possible to generate iPSCs from human patients suffering